Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Total cell‐free DNA (β‐globin gene) distribution in maternal plasma at the second trimester: a new prospective for preeclampsia screening

1 Sept 2004

Abstract excerpt

OBJECTIVES: Levels of cell-free foetal DNA (f-DNA) in maternal plasma are higher in those asymptomatic subjects who will eventually develop preeclampsia. f-DNA is, however, informative only for those women bearing a male foetus, by amplification of Y-specific sequences and represents a small fraction of total circulating DNA that can be dosed by using ubiquitous genes as well as beta-globin. In this study, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Pregnancy and preeclampsia studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15386446
DOI: 10.1002/pd.973

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Total cell‐free DNA (β‐globin gene) distribution in maternal plasma at the second trimester: a new prospective for preeclampsia screeningPMID 15386446Read ↗

Cell-Free Fetal DNA: A Novel Biomarker for Early Prediction of Pre-eclampsia and Other Obstetric Complications.Semantic proximity Read ↗

A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome.Semantic proximity Read ↗

Cell-free fetal DNA and pregnancy-related complications (Review)Semantic proximity Read ↗

Absolute first trimester cell-free DNA levels and their associations with adverse pregnancy outcomesSemantic proximity Read ↗

Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low‐risk nonsymptomatic patientsSemantic proximity Read ↗

Can the quantity of cell-free fetal DNA predict preeclampsia: a systematic reviewSemantic proximity Read ↗

Cell-Free Foetal DNA as a Useful Marker for Preeclampsia PredictionSemantic proximity Read ↗

Quantification of circulatory fetal DNA in the plasma of pregnant women.Semantic proximity Read ↗

Quantitative Analysis of Fetal DNA in Maternal Plasma and Serum: Implications for Noninvasive Prenatal DiagnosisSemantic proximity Read ↗

Total and Fetal Cell-Free DNA Analysis in Maternal Blood as Markers of Placental Insufficiency in Intrauterine Growth RestrictionSemantic proximity Read ↗

Role of Circulating Cell-free DNA Levels in Patients With Severe Preeclampsia and HELLP SyndromeSemantic proximity Read ↗

Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunctionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.